Expertise in
24
conditions

Efthimios Dardiotis

Larisa, ESYE14, GR 
Expertise in
24
conditions
Larisa, ESYE14, GR 

Overview

Efthimios Dardiotis practices practicing medicine in Larisa, Greece.

Dardiotis is highly rated in 24 conditions, according to our data. Their clinical expertise encompasses Dementia, Transient Global Amnesia, Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy, Thrombectomy, and Pacemaker Implantation.

They are actively involved in clinical research, co-authoring 401 peer reviewed articles and participating in 4 clinical trials.

Locations

Larisa, ESYE14, Greece
Other Locations
Trikala, ESYE14 42100, Greece
Marousi, ESYE31, Greece
Volos, ESYE14, Greece
ESYE14, Greece
Athens, ESYE31, Greece
Thessaloniki, ESYE12, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
The Effect of Lifestyle Modifications on Aspects Related to Fatigue, Quality of Life, Health, and Sleepiness in Professional Drivers
The Effect of Lifestyle Modifications on Aspects Related to Fatigue, Quality of Life, Health, and Sleepiness in Professional Drivers
Enrollment Status: Withdrawn
Publish Date: June 05, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
View 3 Less Clinical Trials

401 Total Publications

Very late-onset myasthenia gravis: a systematic review and meta-analysis of sex distribution, thymic pathology and autoantibodies.
Very late-onset myasthenia gravis: a systematic review and meta-analysis of sex distribution, thymic pathology and autoantibodies.
Journal: Journal of neurology
Published: June 29, 2026

Frequently Asked Questions about Efthimios Dardiotis

Is Efthimios Dardiotis a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Efthimios Dardiotis is classified as an Distinguished expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Efthimios Dardiotis participate in research or clinical trials?

Yes. Efthimios Dardiotis has published 401 articles and abstracts on conditions like Dementia. You can view a list of Efthimios Dardiotis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dardiotis's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 81 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile